Dubai Chambers announced that it has signed a Memorandum of Understanding (MoU) with Al Jalila Foundation, donating AED15 million to support the Hamdan Bin Rashid Cancer Hospital, the first fully integrated and comprehensive cancer hospital in Dubai.

Dubai Chambers’ donation to the Hamdan Bin Rashid Cancer Hospital exemplifies their unwavering commitment to enhancing community welfare and supporting critical initiatives that improve quality of life.

The MoU was signed by His Excellency Abdul Aziz Abdulla Al Ghurair, Chairman of Dubai Chambers, and Her Excellency Dr. Raja Easa Al Gurg, Chairperson of Al Jalila Foundation Board of Directors and Dubai Health Board Member, at the Dubai Chambers’ headquarters.

His Excellency Abdul Aziz Abdulla Al Ghurair said: “In line with the vision of His Highness Sheikh Mohammed Bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, to strengthen social responsibility, Dubai Chambers is keen to support national projects that contribute to improving the quality of life and enhancing community services, thereby fostering social and economic development.”

Al Ghurair added: “Our cooperation with Al Jalila Foundation to support the Hamdan Bin Rashid Cancer Hospital reflects our commitment to the principles of social responsibility and the importance of charitable and humanitarian work, as part of our ongoing efforts to effectively contribute to serving the community.”

Expressing her gratitude for the donation, Her Excellency Dr. Raja Al Gurg said: “We are grateful to Dubai Chambers for their generous contribution toward establishing Dubai’s first comprehensive cancer hospital. Through this collaboration and the power of giving, Al Jalila Foundation is paving the way for enhanced care for cancer patients and their families in Dubai. This partnership aligns perfectly with our mission to foster a healthy and sustainable society, enhancing health and wellbeing through humanitarian, developmental, and community-focused efforts.”

Al Jalila Foundation is currently developing the Hamdan Bin Rashid Cancer Hospital, spanning 56,000 square meters. The hospital will feature 50 clinics, 30 clinical research areas, 60 infusion rooms, 10 urgent care rooms, five radiotherapy rooms, and 116 beds, complemented by 19 gardens spread across the campus. These gardens will offer patients space for recovery and opportunities to spend time outdoors with their families, promoting enhanced mental well-being.

The new facility will house a multidisciplinary team, including specialized nursing staff, and will provide integrated healthcare services from initial diagnosis through treatment, ensuring comprehensive care under one roof. Selected treatments and services will also be accessible to patients in their homes, ensuring continuity of affordable care and reflecting Dubai Health’s commitment to prioritizing patient needs.

DP World Foundation has donated Dh15 million to Al Jalila Foundation to support the development of the Hamdan bin Rashid Cancer Hospital, highlighting its commitment to corporate social responsibility and community welfare.
The contribution is part of DP World Foundation's broader efforts to support vital healthcare services and improve access to quality healthcare for cancer patients.
The allocated funds will support the development of Dubai's first integrated cancer hospital, scheduled to open in 2026. The advanced healthcare facility, which is being established in collaboration with the Al Jalila Foundation, will feature 50 clinics, 30 research areas, 60 infusion rooms, and 116 inpatient beds spread across a sprawling 56,000-square-metre campus.
His Excellency Nasser Abdulla Al Neyadi, Chief Officer Group Security, Government Relations & Public Affairs (GRPA), and DP World Foundation, presented the contribution during a visit to the Al Jalila Foundation, including the Mohammed Bin Rashid Biomedical Research Centre, where he met with key healthcare officials and stakeholders.
HE Al Neyadi said: "We are deeply committed to making a real difference in society, and this donation reflects our dedication to supporting healthcare institutions and ensuring that quality care is accessible to everyone. We are proud to contribute to such a respected institution leading the way in cancer care and research. Together, we aspire to foster a healthier future for all."
Dr. Amer Al Zarooni, CEO of the Al Jalila Foundation, said: "We extend heartfelt gratitude to the DP World Foundation for their generous donation towards the Hamdan Bin Rashid Cancer Hospital. The collaboration exemplifies the transformative impact of partnerships in accelerating the delivery of critical healthcare services and further emphasizes Dubai Health's commitment to improving the health and well-being of our community.
Together, with the support of our partners, we are steadfast in our dedication to transforming lives and ensuring better health for everyone."
The philanthropic arm of DP World, DP World Foundation, is committed to promoting social responsibility and supporting those in need, regardless of nationality, race, or religion. Earlier this year, DP World Foundation contributed Dh 10 million to the Mothers' Endowment Campaign launched to support the education of millions around the world.

Building on Dubai Health's vision to advance health for humanity, The Royal Marsden NHS Foundation Trust has been selected to support the clinical and operational development of the Hamdan Bin Rashid Cancer Hospital (HBRCH), Dubai's first integrated, comprehensive cancer hospital.

The partnership marks a significant step forward in enhancing the standard of cancer treatment in Dubai, where specialized and compassionate care will be accessible in one place.

As one of the world's leading hospitals dedicated to cancer diagnosis, treatment, research, and education, The Royal Marsden will work with Dubai Health to establish a model of excellence in comprehensive cancer care at HBRCH. Their renowned expertise will be leveraged across several key areas, including developing specialist, evidence-based models of care, early diagnosis, and treatment pathways that guide patients through every step of their journey.

The HBRCH program of care will span from early detection to treatment, recovery, and post-treatment support. A key focus of this partnership will be building a world-class, specialized team of cancer care professionals. This will involve creating a robust workforce plan, developing advanced training programmers, and fostering a culture of continuous learning. Additionally, the partnership will seek to establish a cancer research program, fostering a culture of discovering transformative advancements in cancer care.

Her Excellency Dr. Raja Easa Al Gurg, Chairperson of Al Jalila Foundation Board of Directors and Member of Dubai Health Board of Directors, said, “We are honored to join forces with The Royal Marsden, a global leader in cancer research and treatment. Their renowned expertise and approach to care perfectly complement the care, learning, discovery, and giving missions of our integrated academic health system. Through this partnership, we are honoring the collective generosity of our esteemed donors whose unwavering support to Al Jalila Foundation is fulfilling our vision for the Hamdan Bin Rashid Cancer Hospital to become a beacon of hope for patients and families facing a cancer diagnosis. It propels us closer to achieving the Dubai Social Agenda 33 goal of delivering a world-class healthcare system of the highest efficiency and quality."

Dame Cally Palmer, Chief Executive, The Royal Marsden, said: “I am delighted that The Royal Marsden has been chosen to work in partnership with Dubai Health to advance the clinical development of the Hamdan Bin Rashid Cancer Hospital. This is an excellent opportunity for international collaboration, and to adapt the best practices in state-of-the-art healthcare provision and establish the structure upon which this advanced, innovative and future-looking hospital can be based.”

“At The Royal Marsden our integrated NHS and Private Care model, underpinned by a research and academic infrastructure, delivers outstanding personalized care for our patients. Through a staged program of work, The Royal Marsden and Dubai Health aim to establish a long-term strategic partnership that will not only develop a new hospital but support specialized cancer care across the wider healthcare system in Dubai,” she added.

Set to open in 2026, the HBRCH will offer a groundbreaking model of care under Dubai Health. As part of Dubai’s first integrated academic health system, the comprehensive cancer hospital will create multidisciplinary teams to spearhead a transformative shift in care delivery. Research and clinical trials will be at the heart of the hospital, fostering a culture of discovery and accelerating progress in cancer care. With 50 clinics, 30 research areas, 60 infusion rooms, and 116 inpatient beds spread across a sprawling 56,000-square-metre campus, the hospital is positioned to become a beacon of hope for cancer patients in the UAE and the region.